VT

Vivek Tyagi

Active Director Director DIN 10896878
DIN 10896878 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Vivek Tyagi

Data last updated:

Vivek Tyagi is a Director at Laurent Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 10896878
Primary Designation Director
Industry Pharma
First Appointment 04 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jan 20252025Active

Board colleagues of Vivek Tyagi

NameDINCompanyDesignation
Vaibhav Tyagi10896879Laurent Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Laurent Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vivek Tyagi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Tyagi

Vivek Tyagi currently holds 1 directorship: Laurent Pharmaceuticals Private Limited (Director, since 04 Jan 2025).

Vivek Tyagi was first appointed on 04 Jan 2025 as Director at Laurent Pharmaceuticals Private Limited.

The current boards of Vivek Tyagi's companies include Vaibhav Tyagi (Laurent Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available